CELC May 2024 20.000 put
| Previous close | 1.9500 |
| Open | 1.9500 |
| Bid | 0.2000 |
| Ask | 4.7000 |
| Strike | 20.00 |
| Expiry date | 2024-05-17 |
| Day's range | 1.9500 - 1.9500 |
| Contract range | N/A |
| Volume | |
| Open interest | 81 |
GlobeNewswireCelcuity To Present at Upcoming Needham and Stifel Investor Conferences
MINNEAPOLIS, April 04, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that Brian Sullivan, Chief Executive Officer, and Co-founder of Celcuity, will present and be available for one-on-one investor meetings at the following investor conferences: A fireside chat at the 23rd Annual Needham Virtual Healthcare Conference at 2:15 p.m. ET on Thursday, April 11, 2024. A live webcast w
Simply Wall St.Celcuity Gains 12%, Insider Trades Reap Benefit
Insiders who bought Celcuity Inc. ( NASDAQ:CELC ) stock in the last 12 months were richly rewarded last week. The...
Insider MonkeyCelcuity Inc. (NASDAQ:CELC) Q4 2023 Earnings Call Transcript
Celcuity Inc. (NASDAQ:CELC) Q4 2023 Earnings Call Transcript March 27, 2024 Celcuity Inc. beats earnings expectations. Reported EPS is $-0.65, expectations were $-0.71. CELC isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen, and welcome to […]
